Date Filer Title Filing Type Shares Traded Price Total Held
Jun 06, 2019
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 21,911 -- 21,911
Jun 06, 2019
Director, Ten Percent Owner
Director, Ten Percent Owner Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 21,911 -- 21,911
Jun 06, 2019
Director, Ten Percent Owner
Director, Ten Percent Owner Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 21,911 -- 21,911
Oct 01, 2018
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 23,230 -- 23,230
Jan 18, 2019
Chief Operating Officer
Chief Operating Officer Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,000 -- 28,219
Jun 06, 2019
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,274 -- 30,274
Feb 15, 2024
CHIEF MEDICAL OFFICER
CHIEF MEDICAL OFFICER Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,081 $1.27 31,487
May 26, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 $0.56 33,000
Mar 06, 2023
General Counsel
General Counsel Form 3 Initial Statement of Beneficial Ownership of Securities -- -- 39,270
Sep 18, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 40,000

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.